Drugs / Yolk antibody
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05410223 | Apr 2021 → Dec 2022 | Helicobacter pylori infectious disease | The Third Xiangya Hospital of Central South University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yolk antibody | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05410223 ↗ |
| Modality | Protein / enzyme biologic | “Yolk antibody” NCT05410223 ↗ |